2,466
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

In vitro prediction of in vivo pseudo-allergenic response via MRGPRX2

, , , , , , & show all
Pages 30-36 | Received 08 Dec 2020, Accepted 13 Jan 2021, Published online: 11 Feb 2021

References

  • Ali H. 2016. Mas-related G protein coupled receptor-X2: A potential new target for modulating mast cell-mediated allergic and inflammatory diseases. J Immunobiol. 2016(1):115.
  • Ali H. 2017. Emerging roles for MAS-related g protein-coupled receptor-X2 in host defense peptide, opioid, and neuropeptide-mediated inflammatory reactions. Adv Immunol. 136:123–162.
  • Allia E, Tarabra E, Volante M, Cerrato M, Ghigo E, Muccioli G, Papotti M. 2005. Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related tumours. J Pathol. 207(3):336–345.
  • Amatya B, Nordlind K, Wahlgren C. 2010. Responses to intradermal injections of Substance P in psoriasis patients with pruritus. Skin Pharmacol Physiol. 23(3):133–138.
  • Baş M, Greve J, Stelter K, Havel M, Strassen U, Rotter N, Veit J, Schossow B, Hapfelmeier A, Kehl V, et al. 2015. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 372(5):418–425.
  • Bulfone-Paus S, Nilsson G, Draber P, Blank U, Levi-Schaffer F. 2017. Positive and negative signals in mast cell activation. Trends Immunol. 38(9):657–667.
  • Charitos I, Castellaneta F, Santacroce L, Bottalico L. 2020. Historical anecdotes and breakthroughs of histamine: From discovery to date. Endocr Metab Immune Disord Drug Targets. 2020. DOI:https://doi.org/10.2174/1871530320666200729150124.
  • Chen R-G, Shen Y-N, Yei J, Wang C-F, Xie D-H, Wang X-H, Zhou J-D, Chen C-Y, Wu Y-L, Gunnarsson R, et al. 2008. A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiency. Acta Paediatr Suppl. 82:32–35.
  • de Antonio M, Rothschild A. 1969. Histamine release and mast cell degranulation induced by 2,4-dinitrophenol in rat tissues. Experientia. 25(3):244–245.
  • Ding Y, Che D, Li C, Cao J, Wang J, Ma P, Zhao T, An H, Zhang T. 2019. Quercetin inhibits MRGPRX2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca2+ fluctuations. Int Immunopharmacol. 66:185–197.
  • Elieh Ali Komi D, Wohrl S, Bielory L. 2020. Mast cell biology at molecular level: A comprehensive review. Clin Rev Allergy Immunol. 58(3):342–365.
  • Erin N, Ersoy Y, Ercan F, Akici A, Oktay S. 2004. NK-1 antagonist CP99994 inhibits stress-induced mast cell degranulation in rats. Clin Exp Dermatol. 29(6):644–648.
  • Garafalo J, Kaplan AP. 1981. Histamine release and therapy of severe dermatographism. J Allergy Clin Immunol. 68(2):103–105.
  • Gaudenzio N, Sibilano R, Marichal T, Starkl P, Reber LL, Cenac N, McNeil BD, Dong X, Hernandez JD, Sagi-Eisenberg R, et al. 2016. Different activation signals induce distinct mast cell degranulation strategies. J Clin Invest. 126(10):3981–3998.
  • Green DP, Limjunyawong N, Gour N, Pundir P, Dong X. 2019. A mast-cell-specific receptor mediates neurogenic inflammation and pain. Neuron. 101(3):412–420.
  • Grimbaldeston M. 2015. Mast cell-MrgprB2: sensing secretagogues or a means to over-react? Immunol Cell Biol. 93(3):221–223.
  • Grimes J, Desai S, Charter N, Lodge J, Santos R, Isidro-Llobet A, Mason A, Wu Z, Wolfe L, Anantharaman L, et al. 2019. MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo-allergic and anaphylactoid reactions. Pharmacol Res Perspect. 7(6):e00547.
  • Hu T, Hou Y, Lu J, Wang X, Wei D, Wang C. 2020. Dextromethorphan, a widely-used cough suppressant, induces local anaphylaxis via MRGPRX2 on mast cells. Chem Biol Interact. 2020:109248.
  • Jensen B, Bartko E, Baumann K, Skov P. 2020. Measuring histamine and cytokine release from basophils and mast cells. Meth Mol Biol. 2163:247–262.
  • Jiang W, Hu S, Che D, An H, Liu R. 2019. A mast-cell-specific receptor mediates Iopamidol-induced immediate IgE-independent anaphylactoid reactions. Int Immunopharmacol. 75:105800.
  • Kimura L, Prezotto-Neto J, Tavora B, Faquim-Mauro E, Pereira N, Antoniazzi M, Jared S, Teixeira C, Santoro M, Barbaro K. 2015. Mast cells and histamine play an important role in edema and leukocyte recruitment induced by Potamotrygon motoro stingray venom in mice. Toxicon. 103:65–73.
  • Kumar M, Singh K, Duraisamy K, Ajarem J, Kwok C, Chow B. 2020. Protective effect of genistein against Compound 48/80-induced anaphylactoid shock via inhibiting MAS related G protein-coupled receptor X2 (MRGPRX2). Molecules. 25(5):1028.
  • Lafleur M, Werner J, Fort M, Lobenhofer E, Balazs M, Goyos A. 2020. MRGPRX2 activation as a rapid, high-throughput mechanistic-based approach for detecting peptide-mediated human mast cell degranulation liabilities. J Immunotoxicol. 17(1):110–121.
  • Lansu K, Karpiak J, Liu J, Huang X-P, McCorvy JD, Kroeze WK, Che T, Nagase H, Carroll FI, Jin J, et al. 2017. In silico design of novel probes for the atypical opioid receptor MRGPRX2. Nat Chem Biol. 13(5):529–536.
  • McNeil B, Pundir P, Meeker S, Han L, Undem B, Kulka M, Dong X. 2015. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature. 519(7542):237–241.
  • Mencarelli A, Gunawan M, Yong K, Bist P, Tan W, Tan S, Liu M, Huang E, Fan Y, Chan J, et al. 2020. A humanized mouse model to study mast cells mediated cutaneous adverse drug reactions. J Leukoc Biol. 107(5):797–807.
  • Ogasawara H, Furuno M, Edamura K, Noguchi M. 2020. Peptides of major basic protein and eosinophil cationic protein activate human mast cells. Biochem Biophys Rep. 21:100719.
  • Olivennes F, Diedrich K, Frydman R, Felberbaum R, Howles C. 2003. Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges: Report of two large multi-centre, multi-national, Phase IIIb clinical experiences. Reprod Biomed Online. 6(4):432–438.
  • Petersen L, Brasso K, Pryds M, Skov P. 1996. Histamine release in intact human skin by mono-cyte chemoattractant factor-1, RANTES, macrophage inflammatory protein-1α, stem cell factor, anti-IgE, and codeine as determined by an ex vivo skin microdialysis technique. J Allergy Clin Immunol. 98(4):790–796.
  • Petersen L, Church M, Skov P. 1997. Histamine is released in the wheal but not the flare following challenge of human skin in vivo: A microdialysis study. Clin Exp Allergy. 27(3):284–295.
  • Petersen L. 1997. Quantitative measurement of extracellular histamine concentrations in intact human skin in vivo by the microdialysis technique: methodological aspects. Allergy. 52(5):547–555.
  • Petersen L. 1998. Measurement of histamine release in intact human skin by microdialysis technique. Clinical and experimental findings. Dan Med Bull. 45(4):383–401.
  • Porebski G, Kwiecien K, Pawica M, Kwitniewski M. 2018. Mas-related G protein-Coupled Receptor-X2 (MRGPRX2) in drug hypersensitivity reactions. Front Immunol. 9:3027.
  • Rothschild A. 1970. Mechanisms of histamine release by Compound 48/80. Br J Pharmacol. 38(1):253–262.
  • Sahid M, Liu S, Mogi M, Maeyama K. 2020. Tachykinin-1 receptor antagonism suppresses Substance-P- and Compound 48/80-induced mast cell activation from rat mast cells expressing functional mas-related GPCR B3. Inflamm Res. 69(3):289–298.
  • Shelburne C, Abraham S. 2011. The mast cell in innate and adaptive immunity. Adv Exp Med Biol. 716:162–185.
  • Siehler S, Nunn C, Hannon J, Feuerbach D, Hoyer D. 2008. Pharmacological profile of somatostatin and cortistatin receptors. Mol Cell Endocrinol. 286(1–2):26–34.
  • Solinski H, Gudermann T, Breit A. 2014. Pharmacology and signaling of MAS-related G protein-coupled receptors. Pharmacol Rev. 66(3):570–597.
  • Subramanian H, Gupta K, Ali H. 2016. Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases. J Allergy Clin Immunol. 138(3):700–710.
  • Suzuki Y, Liu S, Ogasawara T, Sawasaki T, Takasaki Y, Yorozuya T, Mogi M. 2020. A novel MRGPRX2-targeting antagonistic DNA aptamer inhibits histamine release and prevents mast cell-mediated anaphylaxis. Eur J Pharmacol. 878:173104.
  • Theoharides T, Tsilioni I, Ren H. 2019. Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders? Expert Rev Clin Immunol. 15(6):639–656.
  • Varricchi G, Pecoraro A, Loffredo S, Poto R, Rivellese F, Genovese A, Marone G, Spadaro G. 2019. Heterogeneity of human mast cells with respect to MRGPRX2 receptor expression and function. Front Cell Neurosci. 13:299.
  • Wang J, Zhang Y, Che D, Zeng Y, Wu Y, Qin Q, Wang N. 2020. Baicalin induces Mrgprb2-dependent pseudo-allergy in mice. Immunol Lett. 226:55–61.
  • Wei J, Wei X, Mo Y, He S. 2009. Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A2. BMC Immunol. 10:21.
  • Zhan Y, Ma N, Liu R, Wang N, Zhang T, He L. 2019. Polymyxin B and polymyxin E induce anaphylactoid response through mediation of Mas-related G protein-coupled receptor X2. Chem Biol Interact. 308:304–311.
  • Zheng Y, Che D, Peng B, Hao Y, Zhang X, He L, Geng S. 2019. All-trans-retinoic acid activated mast cells via Mas-related G-protein-coupled receptor-X2 in retinoid dermatitis. Contact Dermatitis. 81(3):184–193.